Applied DNA Price To Sales vs. Shares Owned By Institutions

APDN Stock  USD 0.15  0.01  6.25%   
Based on the key profitability measurements obtained from Applied DNA's financial statements, Applied DNA Sciences may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Applied DNA's ability to earn profits and add value for shareholders.

Applied DNA Price To Sales Ratio

1.29

As of the 2nd of December 2024, Price To Sales Ratio is likely to drop to 1.29. In addition to that, Days Sales Outstanding is likely to drop to 7.62. At this time, Applied DNA's Total Other Income Expense Net is very stable compared to the past year. As of the 2nd of December 2024, Net Interest Income is likely to grow to about 91 K, while Operating Income is likely to drop (10.4 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.740.48
Way Up
Slightly volatile
For Applied DNA profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Applied DNA to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Applied DNA Sciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Applied DNA's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Applied DNA Sciences over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Is Electronic Equipment, Instruments & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied DNA. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied DNA listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(7.50)
Revenue Per Share
2.202
Quarterly Revenue Growth
(0.73)
Return On Assets
(0.57)
Return On Equity
(0.76)
The market value of Applied DNA Sciences is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied DNA's value that differs from its market value or its book value, called intrinsic value, which is Applied DNA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied DNA's market value can be influenced by many factors that don't directly affect Applied DNA's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Applied DNA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied DNA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied DNA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Applied DNA Sciences Shares Owned By Institutions vs. Price To Sales Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Applied DNA's current stock value. Our valuation model uses many indicators to compare Applied DNA value to that of its competitors to determine the firm's financial worth.
Applied DNA Sciences is number one stock in price to sales category among its peers. It also is number one stock in shares owned by institutions category among its peers producing about  0.21  of Shares Owned By Institutions per Price To Sales. The ratio of Price To Sales to Shares Owned By Institutions for Applied DNA Sciences is roughly  4.73 . At this time, Applied DNA's Price To Sales Ratio is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Applied DNA's earnings, one of the primary drivers of an investment's value.

Applied Shares Owned By Institutions vs. Price To Sales

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Applied DNA

P/S

 = 

MV Per Share

Revenue Per Share

 = 
2.32 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Applied DNA

Shares Held by Institutions

 = 

Funds and Banks

+

Firms

 = 
0.49 %
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.

Applied Shares Owned By Institutions Comparison

Applied DNA is currently under evaluation in shares owned by institutions category among its peers.

Applied DNA Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Applied DNA, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Applied DNA will eventually generate negative long term returns. The profitability progress is the general direction of Applied DNA's change in net profit over the period of time. It can combine multiple indicators of Applied DNA, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income-9.9 M-10.4 M
Income Before Tax-9 M-9.5 M
Net Loss-9 M-9.4 M
Total Other Income Expense Net837.3 K879.2 K
Income Tax Expense-87.2 K-82.9 K
Net Loss-11.5 M-12.1 M
Net Loss-9.6 M-10.1 M
Non Operating Income Net Other-434.8 K-456.5 K
Interest Income67.8 K64.4 K
Net Interest Income86.6 K91 K
Change To Netincome-2.7 M-2.5 M
Net Loss(7.28)(7.64)
Income Quality 1.15  1.21 
Net Income Per E B T 1.14  1.16 

Applied Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Applied DNA. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Applied DNA position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Applied DNA's important profitability drivers and their relationship over time.

Use Applied DNA in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Applied DNA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Applied DNA will appreciate offsetting losses from the drop in the long position's value.

Applied DNA Pair Trading

Applied DNA Sciences Pair Trading Analysis

The ability to find closely correlated positions to Applied DNA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Applied DNA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Applied DNA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Applied DNA Sciences to buy it.
The correlation of Applied DNA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Applied DNA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Applied DNA Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Applied DNA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Applied DNA position

In addition to having Applied DNA in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Business Services Thematic Idea Now

Business Services
Business Services Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Business Services theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Business Services Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Applied DNA Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Applied DNA's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Applied Dna Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Applied Dna Sciences Stock:
Check out Trending Equities.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
To fully project Applied DNA's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Applied DNA Sciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Applied DNA's income statement, its balance sheet, and the statement of cash flows.
Potential Applied DNA investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Applied DNA investors may work on each financial statement separately, they are all related. The changes in Applied DNA's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Applied DNA's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.